Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
13F holders, Q1 2025
Institutional positions in Wave Life Sciences, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 197
- +14 vs. Q4 2024
- Shares held
- 131.4M
- +3.33M (+2.6%) vs. Q4 2024
- Total value
- $1.06B
- −$522.2M (−33.0%) vs. Q4 2024
- New holders
- 34
- 83 more added
- Sold out
- 20
- 51 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WVE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 239 | $1.06B |
| Q1 2026 | 232 | $1.25B |
| Q4 2025 | 219 | $3.11B |
| Q3 2025 | 189 | $1.05B |
| Q2 2025 | 177 | $903.1M |
| Q1 2025 | 197 | $1.06B |
| Q4 2024 | 184 | $1.59B |
| Q3 2024 | 162 | $986.1M |
| Q2 2024 | 144 | $474.4M |
| Q1 2024 | 132 | $572.3M |
| Q4 2023 | 115 | $468.0M |
| Q3 2023 | 85 | $417.4M |
| Q2 2023 | 81 | $262.7M |
| Q1 2023 | 73 | $303.5M |
| Q4 2022 | 75 | $476.9M |
| Q3 2022 | 61 | $242.8M |
| Q2 2022 | 60 | $220.3M |
| Q1 2022 | 82 | $95.4M |
| Q4 2021 | 90 | $148.5M |
| Q3 2021 | 88 | $183.5M |
| Q2 2021 | 87 | $246.7M |
| Q1 2021 | 102 | $214.8M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Wave Life Sciences, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bamco Inc | 0 | $0 | 0.00% | −85,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −68,927−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −53,419−100.0% | Sold out |
| Handelsbanken Fonder AB | 0 | $0 | 0.00% | −50,800−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −42,564−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −39,767−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −24,461−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,819−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −19,970−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −19,936−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −17,051−100.0% | Sold out |
| Westwood Wealth Management | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −5,133−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −858−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −293−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −217−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |